'1 Drop of Blood' Lung Cancer Test and Its Potential Benefits

Published

By Andy Hsueh/Joyce Tseng

Researchers at central Taiwan's Chung Shan Medical University are developing a blood test that can predict whether lung cancer survivors will relapse. TaiwanPlus speaks to the founder of precision oncology company Empiri Inc. Kyuson Yun for a closer look into its potential.